UPS is adding 27 temperature-controlled facilities globally to handle rising demand for sensitive pharmaceuticals like GLP-1 drugs.
United Parcel Service will invest $48 million to expand its healthcare logistics network, adding 27 cold-chain facilities across the Americas, Europe, and Asia. The move aims to improve transport for temperature-sensitive medications, including GLP-1 drugs, which require strict refrigeration during delivery.
Demand for biologics and specialized therapies is growing, with the temperature-sensitive biologics market projected to expand at an 8.3% annual rate through 2033. Nearly one in eight U.S. adults has used GLP-1 medications, driving the need for enhanced logistics infrastructure.
The expansion will enhance delivery speed and oversight for pharmaceutical products, addressing challenges in transporting sensitive treatments.